Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for Fluidized Bed Granulation Methodology – V 2.0

Posted on By

Tablets: SOP for Fluidized Bed Granulation Methodology – V 2.0

Standard Operating Procedure for Fluidized Bed Granulation Methodology

Department Tablet
SOP No. SOP/TAB/052/2025
Supersedes SOP/TAB/052/2022
Page No. Page 1 of 8
Issue Date 31/10/2025
Effective Date 05/11/2025
Review Date 31/10/2026

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define the methodology for fluidized bed granulation in tablet manufacturing. Fluidized bed granulation is used to enhance the flow properties of powders, improve the uniformity of blends, and ensure the consistency of the final tablet formulation.

2. Scope

This SOP applies to the fluidized bed granulation process for tablet manufacturing. It includes the preparation of raw materials, granulation, drying, and the post-granulation steps required to produce high-quality granules.

3. Responsibilities

  • Manufacturing Personnel: Responsible for following the granulation process and ensuring that the parameters are met for successful granulation.
  • Quality Control (QC): Responsible for testing the granules at different stages of the process, including moisture content, particle size distribution, and flowability, to ensure they meet the required specifications.
  • Quality Assurance (QA): Ensures compliance with GMP standards, verifies the process parameters, and approves the granulation process before moving to the next manufacturing step.
  • Maintenance Personnel: Responsible for ensuring that the fluidized bed granulator is in proper
working condition, calibrated, and ready for use.

4. Accountability

The Production Manager is accountable for ensuring the fluidized bed granulation process is carried out as per this SOP. The QA Manager ensures that the process is validated, the equipment is functioning optimally, and the batch records are complete and accurate.

5. Procedure

5.1 Pre-Granulation Preparation

  1. Ensure that all raw materials (active ingredients, excipients, and binders) are available and meet the required specifications.
  2. Verify that the fluidized bed granulator is clean and free from contamination from previous batches. Perform the necessary cleaning procedures according to the equipment cleaning SOP.
  3. Check that all components of the fluidized bed granulator, such as the air compressor, fluidizing plate, and spray nozzle, are functioning correctly and are in good condition.
  4. Review the formulation and batch records to ensure the granulation parameters, such as binder concentration, granule size, and drying time, are defined.

5.2 Granulation Process

  1. Load the dry powder blend into the fluidized bed granulator, ensuring that the material is evenly distributed.
  2. Start the fluidizing air system to ensure that the material is fluidized and evenly distributed across the bed.
  3. Begin spraying the binder solution onto the powder mixture. Ensure that the binder is added slowly and evenly to promote uniform granule formation. The binder solution should be prepared according to the formulation.
  4. Monitor the granule formation by checking the particle size distribution and texture of the granules. Adjust the spray rate and fluidizing air pressure if necessary to achieve the desired granule characteristics.
  5. If clumping or poor granule formation is observed, adjust the binder solution concentration or spray rate and continue to monitor the process until the desired granule quality is achieved.

5.3 Drying Process

  1. Once the granules have reached the desired size, begin the drying phase by activating the drying system. Ensure the air temperature is set according to the product specifications (typically 40-60°C, depending on the material).
  2. Monitor the drying process carefully to prevent over-drying or under-drying. Use a moisture analyzer to periodically check the moisture content of the granules to ensure they are within the required specifications.
  3. If necessary, adjust the air temperature or airflow rate to achieve uniform drying. The drying time should be optimized to preserve the physical properties of the granules.

5.4 Granule Screening

  1. After drying, screen the granules to remove any oversized or undersized particles. Use an appropriate mesh size sieve based on the desired granule size distribution.
  2. Check the flow properties and bulk density of the granules. If necessary, add a lubricant (such as magnesium stearate) to improve flowability and compressibility for tablet formation.
  3. Ensure that the granules meet the required specifications for tablet compression, including uniformity of size and moisture content.

5.5 Granulation Parameter Optimization

  1. If the granulation process does not yield the desired granule characteristics, optimize the parameters by adjusting the binder concentration, spray rate, fluidizing air pressure, or drying conditions.
  2. After adjustments, perform test runs to verify that the granules meet the desired specifications. Record all changes and test results in the batch record (Annexure-1).
  3. Once optimized, document the final granulation parameters and ensure they are applied consistently in future batches.

5.6 Post-Granulation Inspection

  1. Inspect the granules for uniformity, texture, and particle size distribution. Check for any signs of over-drying, under-drying, or clumping.
  2. Verify that the granules meet the required specifications for hardness, flowability, and moisture content.
  3. If the granules pass all specifications, approve the batch for the next stage of tablet manufacturing (e.g., compression).

5.7 Documentation and Record-Keeping

  1. Document all granulation parameters, adjustments, test results, and batch observations in the batch record (Annexure-1).
  2. Ensure that all changes to the process are recorded in the deviation report (Annexure-2) along with corrective actions taken.
  3. Store all records for the required retention period and ensure they are readily accessible for future audits or regulatory inspections.

5.8 Post-Granulation Equipment Cleaning

  1. After the granulation process, clean the fluidized bed granulator according to the equipment cleaning SOP to prevent contamination between batches.
  2. Perform routine maintenance checks on the fluidized bed granulator, including inspecting and replacing any worn or damaged parts.
  3. Document all cleaning and maintenance activities in the maintenance log (Annexure-3).

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • API: Active Pharmaceutical Ingredient

7. Documents

  1. Batch Record (Annexure-1)
  2. Deviation Report (Annexure-2)
  3. Maintenance Log (Annexure-3)

8. References

  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
  • EU GMP Guidelines Part I – Basic Requirements for Medicinal Products
  • ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Batch Record

Batch Number Granulation Type Binder Type Granule Testing Results Comments
Batch 001 Fluidized Bed PVP Pass: Particle size, moisture content No deviations
Batch 002 Fluidized Bed PVA Pass: Bulk density, flow properties Minor adjustments made to binder concentration

Annexure-2: Deviation Report

Deviation Date Batch Number Deviation Description Corrective Action Responsible Person
15/09/2025 Batch 003 Granules too wet Reduced binder solution rate John Doe

Annexure-3: Maintenance Log

Maintenance Date Equipment Component Maintenance Performed Performed By Comments
12/09/2025 Fluidized Bed Granulator Cleaning, Inspection Jane Smith No issues found, cleaned and calibrated

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP Creation QA Head
01/02/2025 2.0 Updated Granulation Parameters Improved Granule Consistency QA Head
See also  Tablets: SOP for Environmental Monitoring in Manufacturing Areas - V 2.0
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: Ointments: SOP for Cleaning Mixing Tanks Post-Manufacturing – V 2.0
Next Post: SOP for Immediate Quarantine of Raw Materials Suspected of Contamination – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version